跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 6,400 条关于
“BCR-902”
全部
6,400
临床试验
3,178
药物
2,549
机构
30
资讯
643
去年
BioCryst Pharmaceuticals Divests European ORLADEYO Rights for $264 Million to Achieve Debt-Free Status
去年
OBI Pharma Initiates Phase 1/2 Trial for Novel TROP2-Targeted ADC OBI-902 in Advanced Solid Tumors
去年
OBI Pharma's Novel TROP2 ADC OBI-902 Receives FDA IND Clearance for Phase 1/2 Trial Using Proprietary GlycOBI® Technology
6个月前
Digital PCR Outperforms Standard RT-qPCR in Detecting Residual BCR::ABL1 in CML Patients, Enabling Better TKI Discontinuation Decisions
9个月前
Terns Pharmaceuticals Closes $747.5 Million Public Offering to Advance BCR-ABL Inhibitor TERN-701
去年
mRNA Analysis Improves Pre-Operative Prediction of Prostate Cancer Recurrence
3年前
Asciminib Demonstrates Durable Efficacy and Safety in Heavily Pretreated CML-CP Patients
去年
Terns Pharma's TERN-701 Shows Promise in Phase I CML Trial
去年
Enliven Therapeutics' ELVN-001 Shows Promising Phase 1 Data in Chronic Myeloid Leukemia
去年
Bedaquiline Regimens Show Promise in Rifampicin-Resistant Tuberculosis Treatment
第 1 页,共 65 页
上一页
下一页